| Name | Title | Contact Details |
|---|
Women`s Health USA is a provider of value-based care and practice management services to more than 600 women`s health providers across the U.S. With a unique focus on women, Women`s Health USA is an influential player in the development of new cost effective, value-based modes of care delivery. For 22 years, the company has successfully implemented innovative growth strategies and driven streamlined operational costs, payer alignment, ancillary services development, brand development strategies and risk management services. Its unique partnership model enables women`s health groups to operate independently, while leveraging the resources and influence of a national organization.
White Oak Manor-Shelby is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 12 states in 76 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom!
Kolmar Laboratories Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Kolmar Laboratories Inc is based in Port Jervis, NY. You can find more information on Kolmar Laboratories Inc at www.kolmar.com
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company`s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health`s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.